ODAIA

AI-powered commercial insights platform that scores and prioritizes HCP engagement for pharma field teams.

ODAIA, headquartered in Toronto, Canada, provides MAPTUAL, an AI platform that analyzes prescribing, claims, and engagement data to score healthcare professionals and prioritize field-team targeting in near real time. The company raised a Series B round and publicly names large pharma customers. Its focus is HCP-level commercial targeting rather than patient identification, and buyers should evaluate data coverage for their specific markets.

Headquarters
Toronto, Canada
Deployment options
cloud
Website
https://www.odaia.ai
LinkedIn
https://www.linkedin.com/company/odaiaintelligence

Categories

Vendor Scorecard

36% — Limited coverage. Coverage score — how completely Atlas documents ODAIA across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.

Compliance & Validation — Not documented by Atlas

Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?

Deployment & Hosting — Documented

cloud

Pricing Transparency — Not documented by Atlas

Ask the vendor: What is your pricing model, and what drives total cost of ownership?

Implementation & Onboarding — Not documented by Atlas

Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?

Organization & Role Fit — Documented

Mid-Size Biotech, Large Pharma, Top 20 Pharma, Commercial

Solution Scope — Not documented by Atlas

Commercialization

Company Viability — Partially documented

Series B

Always ask the vendor

Not captured in Atlas data — confirm directly. Excluded from the score above.

Data Rights & IP

Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?

Model Credibility & Explainability

Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?

Questions to Ask This Vendor

  • Which data sources power the scoring for our therapeutic area and markets?
  • How is model performance measured against field outcomes?
  • How do scores surface inside our CRM workflow?
  • What does onboarding require from our commercial data team?